☰

Cristina Miller - Publications

Affiliations: 
Carlos Albizu University 
Area:
Clinical Psychology, Personality Psychology, Mental Health, Education
Tree Info Similar researchers PubMed Report error

32 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Elizaldi SR, Lakshmanappa YS, Roh JW, Schmidt BA, Carroll TD, Weaver KD, Smith JC, Deere JD, Dutra J, Stone M, Sammak RL, Olstad KJ, Reader JR, Ma ZM, Nguyen NK, ... ... Miller CJ, et al. SARS-CoV-2 infection induces germinal center responses with robust stimulation of CD4 T follicular helper cells in rhesus macaques. Biorxiv : the Preprint Server For Biology. PMID 32676606 DOI: 10.1101/2020.07.07.191007  0.313
2016 Vaccari M, Gordon SN, Fourati S, Schifanella L, Liyanage NP, Cameron M, Keele BF, Shen X, Tomaras GD, Billings E, Rao M, Chung AW, Dowell KG, Bailey-Kellogg C, Brown EP, ... ... Miller CJ, et al. Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition. Nature Medicine. 22: 762-70. PMID 27239761 DOI: 10.1038/Nm.4105  0.351
2014 Qureshi H, Genescà M, Fritts L, McChesney MB, Robert-Guroff M, Miller CJ. Infection with host-range mutant adenovirus 5 suppresses innate immunity and induces systemic CD4+ T cell activation in rhesus macaques. Plos One. 9: e106004. PMID 25203111 DOI: 10.1371/journal.pone.0106004  0.325
2014 Carroll TD, Matzinger SR, Barry PA, McChesney MB, Fairman J, Miller CJ. Efficacy of influenza vaccination of elderly rhesus macaques is dramatically improved by addition of a cationic lipid/DNA adjuvant. The Journal of Infectious Diseases. 209: 24-33. PMID 24141979 DOI: 10.1093/Infdis/Jit540  0.349
2013 McChesney MB, Miller CJ. New directions for HIV vaccine development from animal models. Current Opinion in Hiv and Aids. 8: 376-81. PMID 23836045 DOI: 10.1097/COH.0b013e328363d3a2  0.352
2012 Genescà M, Ma ZM, Wang Y, Assaf B, Qureshi H, Fritts L, Huang Y, McChesney MB, Miller CJ. Live-attenuated lentivirus immunization modulates innate immunity and inflammation while protecting rhesus macaques from vaginal simian immunodeficiency virus challenge. Journal of Virology. 86: 9188-200. PMID 22696662 DOI: 10.1128/Jvi.00532-12  0.325
2012 Hutnick NA, Myles DJ, Hirao L, Scott VL, Ferraro B, Khan AS, Lewis MG, Miller CJ, Bett AJ, Casimiro D, Sardesai NY, Kim JJ, Shiver J, Weiner DB. An optimized SIV DNA vaccine can serve as a boost for Ad5 and provide partial protection from a high-dose SIVmac251 challenge. Vaccine. 30: 3202-8. PMID 22406458 DOI: 10.1016/J.Vaccine.2012.02.069  0.499
2012 Gordon SN, Kines RC, Kutsyna G, Ma ZM, Hryniewicz A, Roberts JN, Fenizia C, Hidajat R, Brocca-Cofano E, Cuburu N, Buck CB, Bernardo ML, Robert-Guroff M, Miller CJ, Graham BS, et al. Targeting the vaginal mucosa with human papillomavirus pseudovirion vaccines delivering simian immunodeficiency virus DNA. Journal of Immunology (Baltimore, Md. : 1950). 188: 714-23. PMID 22174446 DOI: 10.4049/Jimmunol.1101404  0.343
2012 Qureshi H, Ma ZM, Huang Y, Hodge G, Thomas MA, DiPasquale J, DeSilva V, Fritts L, Bett AJ, Casimiro DR, Shiver JW, Robert-Guroff M, Robertson MN, McChesney MB, Gilbert PB, Miller CJ, et al. Low-dose penile SIVmac251 exposure of rhesus macaques infected with adenovirus type 5 (Ad5) and then immunized with a replication-defective Ad5-based SIV gag/pol/nef vaccine recapitulates the results of the phase IIb step trial of a similar HIV-1 vaccine. Journal of Virology. 86: 2239-50. PMID 22156519 DOI: 10.1128/JVI.06175-11  0.51
2011 Fenizia C, Keele BF, Nichols D, Cornara S, Binello N, Vaccari M, Pegu P, Robert-Guroff M, Ma ZM, Miller CJ, Venzon D, Hirsch V, Franchini G. TRIM5α does not affect simian immunodeficiency virus SIV(mac251) replication in vaccinated or unvaccinated Indian rhesus macaques following intrarectal challenge exposure. Journal of Virology. 85: 12399-409. PMID 21917950 DOI: 10.1128/Jvi.05707-11  0.341
2010 Barnett SW, Burke B, Sun Y, Kan E, Legg H, Lian Y, Bost K, Zhou F, Goodsell A, Zur Megede J, Polo J, Donnelly J, Ulmer J, Otten GR, Miller CJ, et al. Antibody-mediated protection against mucosal simian-human immunodeficiency virus challenge of macaques immunized with alphavirus replicon particles and boosted with trimeric envelope glycoprotein in MF59 adjuvant. Journal of Virology. 84: 5975-85. PMID 20392857 DOI: 10.1128/JVI.02533-09  0.366
2010 Gordon SN, Weissman AR, Cecchinato V, Fenizia C, Ma ZM, Lee TH, Zaffiri L, Andresen V, Parks RW, Jones KS, Heraud JM, Ferrari MG, Chung HK, Venzon D, Mahieux R, ... ... Miller CJ, et al. Preexisting infection with human T-cell lymphotropic virus type 2 neither exacerbates nor attenuates simian immunodeficiency virus SIVmac251 infection in macaques. Journal of Virology. 84: 3043-58. PMID 20071587 DOI: 10.1128/Jvi.01655-09  0.353
2009 Stone M, Ma ZM, Genescà M, Fritts L, Blozois S, McChesney MB, Miller CJ. Limited dissemination of pathogenic SIV after vaginal challenge of rhesus monkeys immunized with a live, attenuated lentivirus. Virology. 392: 260-70. PMID 19647847 DOI: 10.1016/J.Virol.2009.06.052  0.323
2009 Lay M, Callejo B, Chang S, Hong DK, Lewis DB, Carroll TD, Matzinger S, Fritts L, Miller CJ, Warner JF, Liang L, Fairman J. Cationic lipid/DNA complexes (JVRS-100) combined with influenza vaccine (Fluzone) increases antibody response, cellular immunity, and antigenically drifted protection. Vaccine. 27: 3811-20. PMID 19406188 DOI: 10.1016/J.Vaccine.2009.04.054  0.366
2009 Li Q, Skinner PJ, Ha SJ, Duan L, Mattila TL, Hage A, White C, Barber DL, O'Mara L, Southern PJ, Reilly CS, Carlis JV, Miller CJ, Ahmed R, Haase AT. Visualizing antigen-specific and infected cells in situ predicts outcomes in early viral infection. Science (New York, N.Y.). 323: 1726-9. PMID 19325114 DOI: 10.1126/Science.1168676  0.301
2009 Wang Y, Blozis SA, Lederman M, Krieg A, Landay A, Miller CJ. Enhanced antibody responses elicited by a CpG adjuvant do not improve the protective effect of an aldrithiol-2-inactivated simian immunodeficiency virus therapeutic AIDS vaccine. Clinical and Vaccine Immunology : Cvi. 16: 499-505. PMID 19225080 DOI: 10.1128/Cvi.00471-08  0.379
2008 Cecchinato V, Tryniszewska E, Ma ZM, Vaccari M, Boasso A, Tsai WP, Petrovas C, Fuchs D, Heraud JM, Venzon D, Shearer GM, Koup RA, Lowy I, Miller CJ, Franchini G. Immune activation driven by CTLA-4 blockade augments viral replication at mucosal sites in simian immunodeficiency virus infection. Journal of Immunology (Baltimore, Md. : 1950). 180: 5439-47. PMID 18390726 DOI: 10.4049/jimmunol.180.8.5439  0.342
2007 Genescà M, Li J, Fritts L, Chohan P, Bost K, Rourke T, Blozis SA, McChesney MB, Miller CJ. Depo-Provera abrogates attenuated lentivirus-induced protection in male rhesus macaques challenged intravenously with pathogenic SIVmac239. Journal of Medical Primatology. 36: 266-75. PMID 17669215 DOI: 10.1111/J.1600-0684.2007.00244.X  0.317
2006 Zuber B, Quigley MF, Critchfield JW, Shacklett BL, Abel K, Miller CJ, Mörner A, Paulie S, Ahlborg N, Sandberg JK. Detection of macaque perforin expression and release by flow cytometry, immunohistochemistry, ELISA, and ELISpot. Journal of Immunological Methods. 312: 45-53. PMID 16647080 DOI: 10.1016/J.Jim.2006.02.018  0.306
2005 Abel K, Rocke DM, Chohan B, Fritts L, Miller CJ. Temporal and anatomic relationship between virus replication and cytokine gene expression after vaginal simian immunodeficiency virus infection. Journal of Virology. 79: 12164-72. PMID 16160143 DOI: 10.1128/JVI.79.19.12164-12172.2005  0.307
2005 Miller CJ, Li Q, Abel K, Kim EY, Ma ZM, Wietgrefe S, La Franco-Scheuch L, Compton L, Duan L, Shore MD, Zupancic M, Busch M, Carlis J, Wolinsky S, Wolinksy S, et al. Propagation and dissemination of infection after vaginal transmission of simian immunodeficiency virus. Journal of Virology. 79: 9217-27. PMID 15994816 DOI: 10.1128/Jvi.79.14.9217-9227.2005  0.311
2005 Busch M, Abel K, Li J, Piatak M, Lifson JD, Miller CJ. Efficacy of a SHIV 89.6 proviral DNA vaccine against mucosal SIVmac239 challenge. Vaccine. 23: 4036-47. PMID 15963361 DOI: 10.1016/J.Vaccine.2005.03.013  0.383
2004 Yoshino N, Lü FX, Fujihashi K, Hagiwara Y, Kataoka K, Lu D, Hirst L, Honda M, van Ginkel FW, Takeda Y, Miller CJ, Kiyono H, McGhee JR. A novel adjuvant for mucosal immunity to HIV-1 gp120 in nonhuman primates. Journal of Immunology (Baltimore, Md. : 1950). 173: 6850-7. PMID 15557179 DOI: 10.4049/Jimmunol.173.11.6850  0.317
2004 De Rosa SC, Lu FX, Yu J, Perfetto SP, Falloon J, Moser S, Evans TG, Koup R, Miller CJ, Roederer M. Vaccination in humans generates broad T cell cytokine responses. Journal of Immunology (Baltimore, Md. : 1950). 173: 5372-80. PMID 15494483 DOI: 10.4049/jimmunol.173.9.5372  0.316
2004 Abel K, Rourke T, Lu D, Bost K, McChesney MB, Miller CJ. Abrogation of attenuated lentivirus-induced protection in rhesus macaques by administration of depo-provera before intravaginal challenge with simian immunodeficiency virus mac239. The Journal of Infectious Diseases. 190: 1697-705. PMID 15478078 DOI: 10.1086/424600  0.373
2004 LaFranco-Scheuch L, Abel K, Makori N, Rothaeusler K, Miller CJ. High beta-chemokine expression levels in lymphoid tissues of simian/human immunodeficiency virus 89.6-vaccinated rhesus macaques are associated with uncontrolled replication of simian immunodeficiency virus challenge inoculum. Journal of Virology. 78: 6399-408. PMID 15163733 DOI: 10.1128/Jvi.78.12.6399-6408.2004  0.306
2004 Abel K, La Franco-Scheuch L, Rourke T, Ma ZM, De Silva V, Fallert B, Beckett L, Reinhart TA, Miller CJ. Gamma interferon-mediated inflammation is associated with lack of protection from intravaginal simian immunodeficiency virus SIVmac239 challenge in simian-human immunodeficiency virus 89.6-immunized rhesus macaques. Journal of Virology. 78: 841-54. PMID 14694116 DOI: 10.1128/Jvi.78.2.841-854.2004  0.327
2003 Busch M, Lu D, Fritts L, Lifson JD, Miller CJ. Comparison of virology and immunology in SHIV 89.6 proviral DNA and virus-inoculated rhesus macaques. Journal of Medical Primatology. 32: 240-6. PMID 14498984 DOI: 10.1034/J.1600-0684.2003.00029.X  0.324
2003 Abel K, Compton L, Rourke T, Montefiori D, Lu D, Rothaeusler K, Fritts L, Bost K, Miller CJ. Simian-human immunodeficiency virus SHIV89.6-induced protection against intravaginal challenge with pathogenic SIVmac239 is independent of the route of immunization and is associated with a combination of cytotoxic T-lymphocyte and alpha interferon responses. Journal of Virology. 77: 3099-118. PMID 12584336 DOI: 10.1128/Jvi.77.5.3099-3118.2003  0.432
2003 Van Rompay KK, Greenier JL, Cole KS, Earl P, Moss B, Steckbeck JD, Pahar B, Rourke T, Montelaro RC, Canfield DR, Tarara RP, Miller C, McChesney MB, Marthas ML. Immunization of newborn rhesus macaques with simian immunodeficiency virus (SIV) vaccines prolongs survival after oral challenge with virulent SIVmac251. Journal of Virology. 77: 179-90. PMID 12477823 DOI: 10.1128/Jvi.77.1.179-190.2003  0.389
1999 Buge SL, Murty L, Arora K, Kalyanaraman VS, Markham PD, Richardson ES, Aldrich K, Patterson LJ, Miller CJ, Cheng SM, Robert-Guroff M. Factors associated with slow disease progression in macaques immunized with an adenovirus-simian immunodeficiency virus (SIV) envelope priming- gp120 boosting regimen and challenged vaginally with SIVmac251 Journal of Virology. 73: 7430-7440. PMID 10438833 DOI: 10.1128/JVI.73.9.7430-7440.1999  0.381
1995 Kiyono H, Miller CJ, Lu Y, Lehner T, Cranage M, Huang YT, Kawabata S, Marthas M, Roberts B, Nedrud JG, Lamm ME, Bergmeier L, Brookes R, Tao L, McGhee JR. The common mucosal immune system for the reproductive tract: basic principles applied toward an AIDS vaccine Advanced Drug Delivery Reviews. 18: 23-52. DOI: 10.1016/0169-409X(95)00049-D  0.333
Show low-probability matches.